Study of pulmonary functions in male current smokers and never smokers
DOI:
https://doi.org/10.18203/2320-6012.ijrms20240212Keywords:
Current smokers, Never smoker, Pulmonary function testsAbstract
Background: Cigarettes smoking is the principal cause of preventable disease, disability, and premature death in the world. Tobacco smoking affects multiple organ systems resulting in numerous tobacco-related diseases. The study aimed to investigate interrelationship of pulmonary functions between current smokers and never smokers.
Methods: Asymptomatic, 50 males current tobacco smokers and 50 healthy never smokers aged between 25 to 50 years were selected as cases and controls. Detailed description of the subject’s selection, data collection and methods used for performing the test.
Results: Maximum incidence was seen in >31 yrs of age with mean of 38.681±4.5. The study found that never smokers had significantly higher pulmonary functions as compared to current smokers:- FVC in liters (3.43±0.55 Vs 2.44±0.58; p<0.05); FEV1 in liters (2.86±0.57 Vs 1.76±0.32; p<0.05); FEV1/FVC in percentage (82.72±8.67 Vs 73.72±11.40; p<0.05); FEF 25-75 ratio in percentage (3.18±0.91 Vs 1.60±0.45; p<0.05); PEFR in liters per second (6.63±2.00 Vs 3.16±1.26; p<0.05); breath holding time in seconds (25.54±2.14 Vs 21.36±2.10; p<0.05); 40mm endurance test in seconds (22.36±1.58 Vs 17.70±2.01; p<0.05); MEP in mmHg (83.48±5.28 Vs 64.38±5.31; p<0.05) were found significant.
Conclusions: The strong relationship between cigarette smoking and respiratory disease has been seen independent of the other risk factors in a number of well-designated epidemiologic studies. Spirometry is an excellent screening test to detect chronic airflow obstruction, but may be useful in detecting restrictive disorders as well to study the effect of tobacco smoking on pulmonary functions.
Metrics
References
West R, Shiffman S. Fast facts: smoking cessation. Karger Medical and Scientific Publishers; 2016:28.
World Health Organization. "Tobacco Could Kill One Billion By 2100, WHO Report Warns." ScienceDaily. ScienceDaily, 11 February 2008. . Accessed on 15 November 2016.
Tobacco control: country profiles. Atlanta, GA: American Cancer Society; 2000.
World Health Organization. World health report 2002: Reducing risks, promoting healthy life, 2002. Available at: https://www.who.int/publications/i/item/9241562072. Accessed on 18 January 2016.
Crofton J, Bjartveit K. Smoking as a risk factor for chronic airways disease. Chest. 1989;96(3 suppl):307S-12S.
Blann AD. Increased circulating levels of von Willebrand factor antigen in smokers may be due to lipid peroxides. Med Sci Res. 1991;19(16):535-6.
Smith FB, Lowe GD, Fowkes FG, Rumley A, Rumley AG, Donnan PT, et al. Smoking, haemostatic factors and lipid peroxides in a population case control study of peripheral arterial disease. Atherosc. 1993;102(2):155-62.
Meade TW, Imeson J, Stirling Y. Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease. Lancet. 1987;330(8566):986-8.
Ogston D, Bennett NB, Ogston CM. The influence of cigarette smoking on the plasma fibrinogen concentrations. Atherosc. 1970;11(2):349-52.
Craig WY, Palomaki GE, Haddow JE. Cigarette smoking and serum lipid lipoprotein concentrations: an analysis of published data. Br Med J. 1989;298(6676):784-8.
Duthie GG, Arthur JR, James PT. Effects of smoking and vitamin E on blood anti-oxidant status. Am J Clin Nutr. 1990;40:273-87.
Leone A. Relationship between cigarette smoking and other coronary risk factors in atherosclerosis: risk of cardiovascular disease and preventive measures. Curr Pharmac Desi. 2003;9(29):2417-23.
Stavem K, Aaser E, Sandvik L, Bjørnholt JV, Erikssen G, Thaulow E, et al. Lung function, smoking and mortality in a 26-year follow-up of healthy middle-aged males. Euro Respir J. 2005;25(4):618-25.
Johnson BD, Beck KC, Olson LJ, O’Malley KA, Allison TG, Squires RW, et al. Pulmonary function in patients with reduced left ventricular function: influence of smoking and cardiac surgery. Chest. 2001;120(6):1869-76.
Clark KD, Wardrobe-Wong N, Elliott JJ, Gill PT, Tait NP, Snashall PD. Patterns of lung disease in a “normal” smoking population: are emphysema and airflow obstruction found together?. Chest. 2001;120(3):743-7.
Downloads
Published
How to Cite
Issue
Section
